Juntendo Medical Journal

〈Original Articles〉 1)Oh S, Suzuki K, Miyasaka Y, Matsunaga T, Tsushima Y, Takamochi K: New technique for lung segmentectomy using indocyanine green injection. Ann Thorac Surg, 2013; 95: 2188-2190. 2)Takamochi K, Takeuchi K, Hayashi T, Oh S, Suzuki K: A rational diagnostic algorithm for the identification of ALK rearrangement in lung cancer: a comprehensive study of surgically treated Japanese patients. PLoS One, 2013; 8: e69794. 3)Takamochi K, Oh S, Suzuki K: Differences in EGFR and KRAS mutation spectra in lung adenocarcinoma of never and heavy smokers. Oncol Lett, 2013; 6: 1207-1212. 4)Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S: The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Eur J Cardiothorac Surg, 2013; 44: 83-87. 5)Matsunaga T, Suzuki K, Takamochi K, Oh S: Time to refine N2 staging? N2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved. Eur J Cardiothorac Surg, Epub 2013 Dec 8. * 6)Matsunaga T, Suzuki K, Hattori A, Fukui M, Kitamura Y, Miyasaka Y, Takamochi K, Oh S: Lung cancer with scattered consolidation: detection of new independent radiological category of peripheral lung cancer on thinsection computed tomography. Interact Cardiovasc Thorac Surg, 2013; 16: 445-449. 7)Hattori A, Suzuki K, Maeyashiki T, Fukui M, Kitamura Y, Matsunaga T, Miyasaka Y, Takamochi K, Oh S: The presence of air bronchogram is a novel predictor of negative nodal involvement in radiologically puresolid lung cancer. Eur J Cardiothorac Surg, Epub 2013 Oct 17. 8)Hattori A, Suzuki K, Matsunaga T, Fukui M, Tsushima Y, Takamochi K, Oh S: Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan. Interact CardioVasc Thorac Surg, Epub 2013 Dec 18. 9)Ichinokawa H, Ishii G, Nagai K, Kawase A, Yoshida J, Nishimura M, Hishida T, Ogasawara N, Tsuchihara K, Ochiai A: Distinct clinicopathologic characteristics of lung mucinous adenocarcinoma with KRAS mutation. Hum Pathol, 2013; 44: 2636-2642. 10)Kozu Y, Isaka M, Ohde Y, Takeuchi K, Nakajima T: Epithelioid inflammatory myofibroblastic sarcoma arising in the pleural cavity. Gen Thoracic and Cardiovasc Surg, Epub 2013 Jan 24. 11)Kozu Y, Maniwa T, Takahashi S, Isaka M, Ohde Y, Nakajima T: Risk factors for both recurrence and survival in patients with pathological stage I non-small cell lung cancer. Eur J Cardiothorac Surg, 2013; 44: e53-58. 12)Kozu Y, Isaka M, Ohde Y, Nakajima T: Aggressive adenocarcinoma of the lung consisting solely of discohesive cells. J Cardiothorac Surg, 2013; 8: 89. 13)Kozu Y, Maniwa T, Takahashi S, Isaka M, Ohde Y, Nakajima T: Prognostic significance of postoperative serum carcinoembryonic